![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Alex Thompson Initiated (VTYX) at Strong Buy and Held Target at $45 on, Sep 7th, 2022
Alex Thompson of Stifel, Initiated "Ventyx Biosciences, Inc." (VTYX) at Strong Buy and Held Target at $45 on, Sep 7th, 2022.
Alex has made no other calls on VTYX in the last 4 months.
There are 4 other peers that have a rating on VTYX. Out of the 4 peers that are also analyzing VTYX, 0 agree with Alex's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Alex
- Emily Bodnar of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $36 on, Thursday, September 1st, 2022
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 17th, 2022
- Jeff Jones of "Oppenheimer" Maintained at Buy with Increased Target to $40 on, Tuesday, August 16th, 2022
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $63 on, Tuesday, August 16th, 2022
Contributing Sources